1. Karnofsky, D.A.: Meaningful clinical classification of therapeutic responses to anticancer drugs, Clinc. Pharm. Ther. 2: 709–712, 1961.
2. Kurokawa, T., Hattori, T. and Furue, H.: Clinical experiences with the streptococcal anticancer preparation, OK-432 (NSC-B-116209), Cancer Chemother. Rep. Pt. I. 56: 211–220, 1972.
3. Ohashi, F. and Tsukagoshi, S.: Combination therapy of mice bearing syngeneic tumor, leukemia P 388 with the streptococcal preparation (OK-432) and cyclophosphamide, GANN. 65: 563, 1974.
4. Okamoto, H., Minami, M., Shoin, S., Koshimura, S., and Shimizu, R.: Experimeptal anticancer studies. Part XXXI On the streptococcal preparation having potent anticancer activity. Jap. J. Exp. Med. 36: 175–186, 1966.
5. Okamoto, H., Shoin, S., Koshimura, S., and Shimizu, R.: Studies on the anticancer and streptocysin S forming activities of hemolytic streptococci, Jap. J. Microbiol. 11: 323–336, 1967.